These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 10805420)

  • 1. Changes in plasma angiotensin-converting enzyme activity and noradrenaline responses to long-term nitric oxide inhibition vary depending on their basal values in chickens.
    Aksulu HE; Bingöl I; Karatas F; Sagmanligil H; Ustündag B
    Physiol Res; 2000; 49(1):175-82. PubMed ID: 10805420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term lisinopril dihydrate application decreases plasma noradrenaline but not adrenaline levels in chickens.
    Ozdemir HS; Aksulu HE; Karataş F; Ustündag B; Bingöl I
    Physiol Res; 2000; 49(1):183-8. PubMed ID: 10805421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nitric oxide synthase modulation on resuscitation success in a swine ventricular fibrillation cardiac arrest model.
    Zhang Y; Boddicker KA; Rhee BJ; Davies LR; Kerber RE
    Resuscitation; 2005 Oct; 67(1):127-34. PubMed ID: 16039037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats.
    Takemoto M; Egashira K; Usui M; Numaguchi K; Tomita H; Tsutsui H; Shimokawa H; Sueishi K; Takeshita A
    J Clin Invest; 1997 Jan; 99(2):278-87. PubMed ID: 9005996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked variation in responses to long-term nitric oxide inhibition during pregnancy in outbred rats from two different colonies.
    Buhimschi IA; Shi SQ; Saade GR; Garfield RE
    Am J Obstet Gynecol; 2001 Mar; 184(4):686-93. PubMed ID: 11262473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide (NO) modulation of PAF-induced cardiopulmonary action: interaction between NO synthase and cyclo-oxygenase-2 pathways.
    Fabi F; Calabrese R; Stati T; del Basso P
    Br J Pharmacol; 2001 Oct; 134(4):777-88. PubMed ID: 11606318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine.
    Tozer GM; Prise VE; Chaplin DJ
    Cancer Res; 1997 Mar; 57(5):948-55. PubMed ID: 9041200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of captopril on cardiac and renal damage, and metabolic alterations in the nitric oxide-deficient hypertensive rat.
    Khattab MM; Mostafa A; Al-Shabanah O
    Kidney Blood Press Res; 2005; 28(4):243-50. PubMed ID: 16220007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salt and nitric oxide inhibition induced hypertension: the role of prostacycline and 8-isoprostane.
    Ilhan S; Oktar S; Sahna E; Aksulu HE
    Clin Exp Hypertens; 2011; 33(2):84-8. PubMed ID: 21214402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of blockade of nitric oxide synthase and angiotensin-converting enzyme on renal function in conscious rabbits.
    Evans RG; Rankin AJ; Anderson WP
    J Cardiovasc Pharmacol; 1994 Oct; 24(4):542-51. PubMed ID: 7528836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo and in vitro evidence of altered nitric oxide metabolism in the spontaneously diabetic, insulin-dependent BB/Edinburgh rat.
    Lindsay RM; Peet RS; Wilkie GS; Rossiter SP; Smith W; Baird JD; Williams BC
    Br J Pharmacol; 1997 Jan; 120(1):1-6. PubMed ID: 9117082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of nitric oxide synthase inhibitors on the vasopressin-induced pituitary-adrenocortical activity and hypothalamic catecholamine levels.
    Bugajski J; Gadek-Michalska A; Głód R; Borycz J
    J Physiol Pharmacol; 1998 Dec; 49(4):617-26. PubMed ID: 10069702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous NO regulates plasminogen activator inhibitor-1 during angiotensin-converting enzyme inhibition.
    Brown NJ; Muldowney JA; Vaughan DE
    Hypertension; 2006 Mar; 47(3):441-8. PubMed ID: 16432054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereospecific pharmacodynamics and chiral inversion of NG-nitro-arginine in the beagle dogs.
    Xin YF; Gu LQ; Zhang S; Bai YS; Zhou GL; You ZQ; Xuan YX
    Chirality; 2010 Nov; 22(10):896-900. PubMed ID: 20872664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma adrenaline responses to long-term modification of blood pressure in normotensive rats and hypertensive rats.
    Jablonskis LT; Howe PR
    J Hypertens; 1995 Mar; 13(3):319-25. PubMed ID: 7622853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition.
    Inaba S; Iwai M; Furuno M; Kanno H; Senba I; Okayama H; Mogi M; Higaki J; Horiuchi M
    J Hypertens; 2011 Nov; 29(11):2236-45. PubMed ID: 21946695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
    Tarsitano CA; Paffaro VA; Pauli JR; da Silva GH; Saad MJ; Salgado I; da Cruz-Höfling MA; Hyslop S
    Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine.
    Toba H; Nakagawa Y; Miki S; Shimizu T; Yoshimura A; Inoue R; Asayama J; Kobara M; Nakata T
    Hypertens Res; 2005 Aug; 28(8):689-700. PubMed ID: 16392774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis.
    Katoh M; Egashira K; Mitsui T; Chishima S; Takeshita A; Narita H
    J Mol Cell Cardiol; 2000 Jan; 32(1):73-83. PubMed ID: 10652192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.